FAUCI Act
Latest action · Nov 3, 2021 Read twice and referred to the Committee on Foreign Relations.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedNov 3, 2021
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Fairness and Accountability in Underwriting Chinese Institutions Act or the FAUCI Act
This bill prohibits making any federal funding available to laboratories or research institutions in China for gain-of-function research. The President may waive this prohibition for national security interests. (Under the bill, gain-of-function research generally involves the enhancement of potential pandemic pathogens or related risky research with potentially dangerous pathogens.)
Furthermore, if the Office of the Inspector General of the Department of Health and Human Services determines that a National Institutes of Health official, employee, or grantee has intentionally misled or omitted information in a relevant disclosure (e.g., to Congress) about federal funding for international gain-of-function research, such a person shall be ineligible for any federal funding or federal employment.
Cosponsors 4
Members who signed on, in the order they did. Signatures ran from Nov 3, 2021 to Nov 16, 2021, with 3 there on the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-FL | Marco Rubio | Original | Nov 3, 2021 |
| R-IN | Mike Braun | Original | Nov 3, 2021 |
| R-MS | Roger F. Wicker | Original | Nov 3, 2021 |
| R-SD | John Thune | Nov 16, 2021 |
Actions 2
Everything that happened, newest first.
- Nov 3, 2021Introduced in Senate
- Nov 3, 2021Read twice and referred to the Committee on Foreign Relations.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 5988 | FAUCI Act | Identical bill | Nov 17, 2021 |
Subjects
Assigned by the Library of Congress. Policy area: International Affairs.
- Asia
- Cardiovascular and respiratory health
- China
- Congressional oversight
- Department of Health and Human Services
- Drug trafficking and controlled substances
- Government employee pay, benefits, personnel management
- Government ethics and transparency, public corruption
- Government studies and investigations
- Health programs administration and funding
- Infectious and parasitic diseases
- International Affairs
- Medical research
- National Institutes of Health (NIH)
- Public contracts and procurement
- Research administration and funding
- World health
Text 1
Each version as it was printed, newest first.
- Nov 3, 2021Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.